Astrana Health, Inc. (AMEH) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Laboratory Corp. of America Holdings

Quest Diagnostics, Inc.

IQVIA Holdings, Inc.

Teladoc Health, Inc.

Psychemedics Corp.

Astrana Health, Inc.

AMN Healthcare Services, Inc.

Select Medical Holdings Corp.

Premier, Inc.

National Research Corp.

Why is Astrana Health, Inc. ?

The company has declared Negative results for the last 4 consecutive quarters

PRE-TAX PROFIT(Q) At USD 6.48 MM has Fallen at -49.8%
NET PROFIT(Q) At USD 0.53 MM has Fallen at -91.7%
ROCE(HY) Lowest at 1.29%

With ROE of 1.24%, it has a very expensive valuation with a 1.79 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -24.68%, its profits have fallen by -82.9%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -24.68% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Astrana Health, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Astrana Health, Inc.

-23.24%

-0.53

74.19%

S&P 500

13.68%

0.71

19.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

33.26%

EBIT Growth (5y)

-1.48%

EBIT to Interest (avg)

9.93

Debt to EBITDA (avg)

0.40

Net Debt to Equity (avg)

0.22

Sales to Capital Employed (avg)

1.65

Tax Ratio

40.84%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

65.73%

ROCE (avg)

20.10%

ROE (avg)

19.00%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

144

Industry P/E

Price to Book Value

1.79

EV to EBIT

32.51

EV to EBITDA

20.12

EV to Capital Employed

1.44

EV to Sales

0.68

PEG Ratio

Dividend Yield

ROCE (Latest)

4.44%

ROE (Latest)

1.24%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company

CASH AND EQV(HY)

Highest at USD 805.57 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 9.3 times

NET SALES(Q)

Highest at USD 956.05 MM

-26What is not working for the Company

PRE-TAX PROFIT(Q)

At USD 6.48 MM has Fallen at -49.8%

NET PROFIT(Q)

At USD 0.53 MM has Fallen at -91.7%

ROCE(HY)

Lowest at 1.29%

DEBT-EQUITY RATIO (HY)

Highest at 80.43 %

RAW MATERIAL COST(Y)

Grown by 41.31% (YoY

INTEREST(Q)

Highest at USD 17.72 MM

Here's what is working for Astrana Health, Inc.

Net Sales

At USD 956.05 MM has Grown at 58.08%

over average net sales of the previous four periods of USD 604.78 MM

MOJO Watch

Near term sales trend is very positive

Net Sales (USD MM)

Net Sales

Highest at USD 956.05 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

Cash and Eqv

Highest at USD 805.57 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio

Highest at 9.3 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Depreciation

Highest at USD 15.6 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Depreciation

At USD 15.6 MM has Grown at 125.88%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (USD MM)

Here's what is not working for Astrana Health, Inc.

Pre-Tax Profit

At USD 6.48 MM has Fallen at -49.8%

over average net sales of the previous four periods of USD 12.9 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD 0.53 MM has Fallen at -91.7%

over average net sales of the previous four periods of USD 6.34 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Interest

At USD 17.72 MM has Grown at 140.02%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debt-Equity Ratio

Highest at 80.43 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest

Highest at USD 17.72 MM

in the last five periods and Increased by 140.02% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Raw Material Cost

Grown by 41.31% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales